Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1F 18 T807----2件: 2, 127
2F-18----2件: 5, 127
3F-18 3F4AP----1件: 13
4F-18 AV 1451----2件: 5, 127
5F-18 FDG----1件: 127
6F-18 FEDAA1106 (BAY85-8101)----1件: 13
7F-18 FPCIT----1件: 6
8F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid)----1件: 299
9F13CD----1件: 288
10F18CETO----1件: 75
11F8IL10----2件: 46, 97
12F8VR----1件: 288
13FAB122----1件: 2
14FABRAZYME1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
15Fabrazyme (agalsidase beta)1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
16Fabrazyme (agalsidase beta) 1 mg/kg1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
17FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
18Fabrazyme 35 mg1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
19Fabrazyme 5 mg1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
20FACS analyses----1件: 65
21FACTANE 200 IU/ml----1件: 288
22Factor VIII1件: Beroctocog alfa---1件: 288
23Factor VIII concentrate1件: Beroctocog alfa---1件: 288
24Factor von Willebrand1件: Von Willebrand factor human---1件: 288
25FACTOR X1件: Coagulation factor X human---1件: 288
26Factor XIIa antagonist monoclonal antibody----1件: 85
27Factor XIII1件: Factor XIII (human)---3件: 51, 97, 288
28Factor XIII Concentrate (Human)1件: Factor XIII (human)---1件: 288
29Factor XIII Concentrate (Human), Pasteurized1件: Factor XIII (human)---1件: 288
30Faecal matter----1件: 97
31Faecal Microbiota Transplant----1件: 97
32Faecal microbiota transplantation----5件: 46, 84, 96, 97, 271
33Faecal sampling----1件: 46
34FAM Therapy----1件: 228
35FamC-1----1件: 2
36Famciclovir1件: Famciclovir1件: D00317 --2件: 11, 13
37FAMOTIDINA1件: Famotidine1件: D00318 1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬1件: 61
38Famotidine1件: Famotidine1件: D00318 1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬5件: 6, 46, 86, 98, 107
39Famotidine 20 MG1件: Famotidine1件: D00318 1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬1件: 86
40FAMPRIDINA1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
41FAMPRIDINE1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14
42Fampridine SR1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
43Fampridine-SR1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
44Fampridine-SR b.i.d. (Twice Daily)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
45FAMPYRA1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14
46FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
47Fampyra 10 mg prolonged-release tablets2件: Dalfampridine,
Manganese citrate		1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
48Fampyra 10mg prolonged release tablets2件: Dalfampridine,
Manganese citrate		1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
49Fang yi qing feng shi granule----1件: 46
50FANG(30)----1件: 46
51Fanhdi----1件: 288
52FANHDI 100 UI----1件: 288
53Fanhdi 100 UI FVIII-120 UI FVW----1件: 288
54FANHDI 25 UI----1件: 288
55Fanhdi 25 UI FVIII-30 UI FVW----1件: 288
56FANHDI 250UI*1F 250UI+F 10ML----1件: 288
57FANHDI 50 UI----1件: 288
58Fanhdi 50 UI FVIII-60 UI FVW----1件: 288
59FANHDI*INF FL 250UI+SIR SOLV+S----1件: 288
60FANHDI*INF FL 500UI+SIR SOLV+S----1件: 288
61FANHDI*INF FL1000UI+SIR SOLV+S----1件: 288
62FANHDI*INF FL250UI+SIR SOLV+S----1件: 288
63Fansidar (pyrimethamine and sulfadoxine)2件: Pyrimethamine,
Sulfadoxine		2件: D00488 ,
D00580 		--1件: 65
64Fasenra1件: Benralizumab1件: D09874 1件: IL5RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299
65Faslodex1件: Fulvestrant1件: D01161 2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 49
66Fasudil1件: Fasudil1件: D07941 2件: ROCK1,
ROCK2 💬		23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 2, 5, 7, 51
67Fasudil (WP-0512)1件: Fasudil1件: D07941 2件: ROCK1,
ROCK2 💬		23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2
68FASUDIL HYDROCHLORIDE1件: Fasudil1件: D07941 2件: ROCK1,
ROCK2 💬		23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2
69Fat diet----1件: 78
70Fatigue----1件: 13
71FAXE Kondi----1件: 257
72Faxe Kondi Free----1件: 257
73Fazisiran Injection----1件: 231
74FB-101----1件: 6
75FB704A----1件: 46
76FBL-MTX----1件: 46
77FBS0701----1件: 284
78FBS0701 CAPSULE----1件: 284
79FBS0701/SSP004184----1件: 284
80FBX-101----1件: 19
81Fc- and CDR-modified humanised monoclonal antibody against C5----3件: 11, 62, 109
82FCM----1件: 222
83FCR001----1件: 51
84FCX-007----1件: 36
85FCX-013----1件: 51
86FDC macitentan/tadalafil2件: Macitentan,
Tadalafil		2件: D02008 ,
D10135 		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
87FDG----1件: 84
88FDL1691件: FDL169---1件: 299
89FDL176----1件: 299
90FDL176 & FDL169 coadministration1件: FDL169---1件: 299
91FE 992097----1件: 193
92FE 999301----2件: 96, 97
93Feburane----1件: 21
94Febuxostat1件: Febuxostat1件: D01206 1件: XDH 💬6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬3件: 2, 6, 13
95Fecal Microbial transplant----2件: 96, 97
96Fecal microbial transplant (FMT)----1件: 13
97Fecal Microbial Transplantation----2件: 96, 97
98Fecal Microbial Transplants----1件: 13
99Fecal microbiota----3件: 13, 96, 97
100Fecal microbiota capsule----1件: 97
101Fecal Microbiota Enema----1件: 97
102Fecal Microbiota Transplant----2件: 96, 97
103Fecal Microbiota Transplant (FMT)----2件: 96, 97
104Fecal microbiota transplantation----5件: 2, 66, 94, 96, 97
105Fecal Microbiota Transplantation (FMT)----2件: 96, 97
106Fecal Microbiota Transplantation (FMT), OpenBiome----1件: 97
107Fecal Microbiota Transplantation by Intra-rectal enemas----1件: 97
108Fecal Microbiota Transplantation by Stool capsules----1件: 97
109Fecal transplantation----1件: 97
110Felzartamab1件: Felzartamab---2件: 66, 222
111Femoston 1/10----1件: 13
112Femoston 2/10----1件: 13
113Fendrix1件: Hepatitis B Vaccine (Recombinant)---1件: 46
114Fendrix suspension for injection1件: Hepatitis B Vaccine (Recombinant)---1件: 46
115Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed).1件: Hepatitis B Vaccine (Recombinant)---1件: 46
116FENEBRUTINIB1件: Fenebrutinib1件: D11457 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 13
117Fenfluramina1件: Fenfluramine1件: D07945 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬2件: 140, 144
118Fenfluramina Cloridrato1件: Fenfluramine1件: D07945 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬2件: 140, 144
119FENFLURAMINE1件: Fenfluramine1件: D07945 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬4件: 140, 144, 145, 149
120Fenfluramine HCl, DL-Fenfluramine, (±)-Fenfluramine1件: Fenfluramine1件: D07945 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬1件: 144
121FENFLURAMINE HYDROCHLORIDE1件: Fenfluramine1件: D07945 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬2件: 140, 144
122FENFLURAMINE HYDROCHLORIDE (colorless)1件: Fenfluramine1件: D07945 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬2件: 140, 144
123FENFLURAMINE HYDROCHLORIDE (red)1件: Fenfluramine1件: D07945 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬1件: 140
124Fengshigutong Capsule----1件: 271
125Fengshigutong Capsule plus Imrecoxib1件: Imrecoxib---1件: 271
126Fenilbutirato----1件: 2
127Fenofibrate1件: Fenofibrate1件: D00565 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬6件: 8, 79, 93, 94, 97, 265
128Fenofibrate 160mg1件: Fenofibrate1件: D00565 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 97
129Fenofibrate 200mg1件: Fenofibrate1件: D00565 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93
130Fenofibrate Combined With Ursodeoxycholic Acid2件: Fenofibrate,
Ursodeoxycholic acid		2件: D00565 ,
D00734 		2件: NR1H4,
PPARA 💬		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93
131Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)1件: Fenofibrate1件: D00565 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93
132Fenretinide1件: Fenretinide1件: D04162 2件: RARA,
RARB 💬		8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 299
133Fentanyl1件: Fentanyl1件: D00320 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬3件: 46, 70, 215
134Fentanyl (High Dose)1件: Fentanyl1件: D00320 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 215
135Fentanyl (Low Dose)1件: Fentanyl1件: D00320 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 215
136Fentanyl (Low Dose) + Dexmedetomidine2件: Dexmedetomidine,
Fentanyl		2件: D00320 ,
D00514 		4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬		4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215
137Fentanyl transdermal patch1件: Fentanyl1件: D00320 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 46
138Feraheme1件: Ferumoxytol1件: D04177 --1件: 13
139Ferinject----2件: 86, 299
140Ferinject or CosmoFer----1件: 86
141Fermented oyster extract1件: Oyster---1件: 84
142Ferric Carboxy Maltose1件: Maltose1件: D00044 --1件: 96
143FERRIC CARBOXYMALTOSE1件: Ferric carboxymaltose1件: D08920 --4件: 86, 96, 97, 299
144Ferric Maltol1件: Ferric maltol1件: D10833 --1件: 96
145Ferricarboxymaltose----1件: 86
146Ferriprox1件: Deferiprone1件: D07416 --2件: 6, 120
147Ferriprox 500 mg1件: Deferiprone1件: D07416 --1件: 6
148FERRIPROX*100CPR RIV 500MG1件: Deferiprone1件: D07416 --1件: 120
149Ferrograd----1件: 46
150Ferrograd Folic Tablets----1件: 46
151Ferrous sulfate 325mg1件: Sulfate ion---1件: 299
152Ferrous sulphate----2件: 96, 97
153Ferrous sulphate 200mg oral tablet----1件: 227
154Ferrprox (Deferiprone)1件: Deferiprone1件: D07416 --1件: 6
155Ferulic acid1件: Ferulic acid---1件: 127
156Ferumoxytol1件: Ferumoxytol1件: D04177 --1件: 13
157Fesoterodine1件: Fesoterodine1件: D07226 2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6
158Fetal porcine cells, Neurocell-PD----1件: 6
159Fexinidazole1件: Fexinidazole1件: D11252 --1件: 65
160Fexofenadine1件: Fexofenadine1件: D07958 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬2件: 13, 46
161FFP104----2件: 93, 96
162FG-3019----3件: 85, 113, 222
163FG-3019 10mg/mL in 10 mL vials----1件: 85
164Fibrate treatment----1件: 160
165Fibrin1件: Fibrin---1件: 279
166Fibrinogen1件: Fibrinogen human---2件: 14, 65
167Fibrinogen (coagulation factorI)1件: Fibrinogen human---1件: 65
168Fibrinogen concentrate1件: Fibrinogen human---1件: 14
169Fibrinogen Concentrate from Human Plasma1件: Fibrinogen human---1件: 65
170Fibroblasts----1件: 36
171Fibrogammin P----1件: 288
172Fibrogammin® 1250----1件: 51
173Fibrogammin® P----1件: 288
174Fibrogammin®P----1件: 288
175Fibrogammin®P, coagulation factor XIII concentrate (Human)1件: Factor XIII (human)---1件: 51
176Fibrovein----1件: 279
177Fibrovein 3%----1件: 279
178Fig1件: Fig---1件: 2
179Filamentous haemagglutinin1件: Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)---1件: 46
180Filamentous haemagglutinin adsorbed1件: Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)---1件: 46
181FILGOTINIB1件: Filgotinib1件: D10871 1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬6件: 46, 53, 96, 97, 222, 271
182Filgotinib 200mg/day1件: Filgotinib1件: D10871 1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46
183Filgrastim1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬28件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331
184Filgrastim (G-CSF)1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 331
185Filgrastim Hexal1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65
186Filgrastim, Alemtuzumab2件: Alemtuzumab,
Filgrastim		2件: D02802 ,
D03235 		2件: CD52,
CSF3R 💬		6件: , Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65
187Film-coated tablet----1件: 97
188Finamine tablets----1件: 6
189Finasteride1件: Finasteride1件: D00321 1件: SRD5A2 💬3件: Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬1件: 6
190Finely ground flaxseed powder1件: Flax seed---1件: 299
191Fingolimob----1件: 13
192Fingolimob (FTY)----1件: 13
193FINGOLIMOD1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156
194Fingolimod (FTY720)1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 156
195Fingolimod 0.5 mg1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
196Fingolimod 0.5mg1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
197Fingolimod 1.25 mg1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
198FINGOLIMOD HYDROCHLORIDE1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14
199Fingolimodi----1件: 13
200Fingolmod----1件: 13
201Fipamezole1件: Fipamezole---2件: 6, 17
202Fipamezole hydrochloride1件: Fipamezole---2件: 6, 17
203Fipamezole hydrochloride 30 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17
204Fipamezole hydrochloride 60 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17
205Fipamezole hydrochloride 90 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17
206Fipamezole ODT1件: Fipamezole---1件: 6
207Fipamezole ODT Cohort 21件: Fipamezole---1件: 6
208Firategrast1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
209Firategrast (USAN approved name)1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
210Firategrast 150 mg1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
211Firategrast 300 mg1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
212Firategrast gastro-retentive solution1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
213Firategrast immediate release tablet1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
214Firategrast modified release tablet1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
215Firdapse1件: Amifampridine1件: D10228 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 11
216FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE1件: Amifampridine1件: D10228 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 11
217First line DMT----1件: 13
218Fisetin1件: Fisetin---1件: 65
219Fish Oil1件: Fish oil---8件: 13, 46, 49, 66, 96, 260, 294, 299
220Fish oil concentrate1件: Fish oil---1件: 13
221Fish oil supplement1件: Fish oil---1件: 46
222Fish oil, gamma-linolenic acid3件: Fish oil,
Gamolenic acid,
alpha-Linolenic acid		1件: D07213 --1件: 46
223FISH OIL, RICH IN OMEGA-3-ACIDS2件: Fish oil,
Omega-3 fatty acids		---1件: 13
224FISH OIL,RICH IN OMEGA 3 ACIDS1件: Fish oil---1件: 13
225FITC-Adalimumab1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
226Fixed dose combination Ciprofloxacin/Celecoxib2件: Celecoxib,
Ciprofloxacin		2件: D00186 ,
D00567 		1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 2
227FK-506----1件: 60
228FK506----1件: 222
229FK506 level 2-3 ng/ml----1件: 86
230FK506 level 3-5 ng/ml----1件: 86
231FK506 level < 2 ng/ml----1件: 86
232FKB327----1件: 46
233FKB327 AI----1件: 46
234FKB327 PFS----1件: 46
235Flagyl1件: Metronidazole1件: D00409 --2件: 96, 97
236Flavocoxid----1件: 113
237Flavoxate1件: Flavoxate1件: D07961 16件: PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬		18件: Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
238Flaxseed1件: Flax seed---2件: 97, 299
239Flaxseed lignan-enriched complex (FLC)1件: Flax seed---1件: 97
240FLEBOGAMMA 5%----1件: 15
241Flebogamma 5% DIF----1件: 65
242Flecainide1件: Flecainide1件: D07962 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6
243FLECAINIDE ACETATE2件: Acetate,
Flecainide		1件: D07962 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6
244Flecainidum1件: Flecainide1件: D07962 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6
245Flixabi1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
246Flolan1件: Epoprostenol1件: D00106 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
247FLOLAN injection with currently marketed diluent1件: Epoprostenol1件: D00106 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
248FLOLAN injection with reformulated diluent1件: Epoprostenol1件: D00106 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
249FLOLAN TM and Glycine Diluent2件: Epoprostenol,
Glycine		2件: D00011 ,
D00106 		1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
250Flolan®1件: Epoprostenol1件: D00106 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
251FLOLAN™ and Glycine Diluent2件: Epoprostenol,
Glycine		2件: D00011 ,
D00106 		1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
252FLORBETABEN (18F)1件: Florbetaben (18F)---1件: 6
253Florbetapir (18F)1件: Florbetapir (18F)---1件: 127
254Florbetapir 18F----1件: 127
255Florbetapir 18F Injection----1件: 127
256Florbetapir F 18----1件: 6
257Florence 30 µg/mL----1件: 98
258Florence 60 µg/mL----1件: 98
259Florence 90 µg/mL----1件: 98
260Flortaucipir1件: Flortaucipir1件: D11210 1件: MAPT 💬4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬3件: 5, 7, 127
261Flortaucipir F181件: Flortaucipir1件: D11210 1件: MAPT 💬4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬3件: 5, 7, 127
262Floseal----1件: 227
263Flovent----1件: 98
264FLT190----1件: 19
265FLT201----1件: 19
266Flu-ATG----1件: 60
267Flucinolone acetonide----1件: 56
268FLUCLOXACILLIN1件: Flucloxacillin1件: D04196 --1件: 299
269Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution1件: Flucloxacillin1件: D04196 --1件: 299
270FLUCLOXACILLIN SODIUM1件: Flucloxacillin1件: D04196 --1件: 299
271Flucloxicillin----1件: 299
272FLUCONAZOLE1件: Fluconazole1件: D00322 --2件: 96, 225
273FLUDARA1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
274Fludarabina1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 19, 65
275Fludarabina Accord1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65
276FLUDARABINA ACCORD - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 5 FLACONCINI IN VETRO DA 2 ML1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 19
277FLUDARABINA FOSFATO1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 19
278FLUDARABINA TEVA - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO DI VETRO DA 2 ML1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65
279Fludarabine1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬19件: 11, 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326
280Fludarabine (FLU)1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 60, 285
281Fludarabine monophosphate1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬3件: 65, 284, 326
282Fludarabine phosphate2件: Fludarabine,
Phosphate ion		1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬12件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286
283Fludarabine phosphate 30 mg2件: Fludarabine,
Phosphate ion		1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164
284Fludarabine phosphate 40 mg2件: Fludarabine,
Phosphate ion		1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164
285Fludarabine, Busulfan, Thymoglobulin3件: Antithymocyte immunoglobulin (rabbit),
Busulfan,
Fludarabine		2件: D00248 ,
D07966 		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65
286Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		3件: D00287 ,
D07760 ,
D07966 		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60
287Fludarabine, Melphalan, Thiotepa3件: Fludarabine,
Melphalan,
Thiotepa		3件: D00369 ,
D00583 ,
D07966 		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65
288Fludarabine/ melphalan2件: Fludarabine,
Melphalan		2件: D00369 ,
D07966 		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60
289Fludarabine/busulfan2件: Busulfan,
Fludarabine		2件: D00248 ,
D07966 		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60
290Fludeoxyglucose1件: Fludeoxyglucose1件: D01843 --3件: 84, 85, 88
291Fludrocortisone1件: Fludrocortisone1件: D07967 1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬3件: 6, 17, 81
292Fluimucil----4件: 85, 94, 193, 298
293Fluimucil (acetylcysteine)1件: Acetylcysteine1件: D00221 --1件: 193
294FLUIMUCIL*20CPR EFF 600MG----2件: 94, 298
295Fluimucil® 600 mg effervescent tablets----1件: 85
296Flumazenil1件: Flumazenil1件: D00697 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬5件: 6, 13, 17, 18, 206
297FluMist1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---1件: 299
298Flumist®1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---1件: 299
299Fluocinolone1件: Fluocinolone---1件: 90
300Fluocinolone Acetonide2件: Fluocinolone,
Fluocinolone acetonide		1件: D01825 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 90
301Fluorescein1件: Fluorescein1件: D01261 --2件: 22, 97
302Fluorescence in situ hybridization----1件: 285
303Fluorescite----1件: 215
304FLUORINE (18F) FLUDEOXYGLUCOSE1件: Fludeoxyglucose1件: D01843 --2件: 84, 85
305FLUORINE-181件: Fluorine F-181件: D05860 --1件: 41
306Fluorodeoxyglucose----1件: 84
307Fluoxetin1件: Fluoxetine1件: D00326 1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬3件: 13, 179, 206
308Fluoxetin Hexal1件: Fluoxetine1件: D00326 1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13
309FLUOXETINE1件: Fluoxetine1件: D00326 1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 13, 17, 78, 86
310FLUOXETINE HYDROCHLORIDE1件: Fluoxetine1件: D00326 1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13
311Fluoxétine1件: Fluoxetine1件: D00326 1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 17
312Flupentixol1件: Flupentixol1件: D01044 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 97
313Flupirtin----1件: 13
314Flupirtine1件: Flupirtine1件: D07978 --1件: 13
315Flupirtinmaleat----1件: 13
316FLURBIPROFEN1件: Flurbiprofen1件: D00330 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬3件: 13, 21, 46
317Flutamide1件: Flutamide1件: D00586 1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 81
318Flutemetamol1件: Flutemetamol (18F)---4件: 5, 6, 7, 127
319Fluticasone1件: Fluticasone1件: D07981 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 98, 228, 299
320Fluticasone MDI1件: Fluticasone1件: D07981 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
321FLUTICASONE PROPIONATE1件: Fluticasone propionate1件: D01708 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 98, 228
322Fluticasone Propionate, USP2件: Fluticasone,
Fluticasone propionate		2件: D01708 ,
D07981 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
323Fluvastatin1件: Fluvastatin1件: D07983 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 79, 218, 222
324Fluzone1件: Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated)---2件: 21, 49
325Fluzone®1件: Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated)---1件: 21
326FLX-787-ODT----1件: 2
327FLX-787-ODT (orally disintegrating tablet)----1件: 10
328FLX-787-ODT (orally disintigrating tablet)----1件: 2
329FMP-30----1件: 53
330FMP30 Donor Stool----1件: 13
331FMT----2件: 96, 97
332FMT enema----1件: 97
333FMT infusions----1件: 97
334FMT oral----1件: 97
335Focetria----1件: 46
336Focetria (Monovalent MF59-Adjuvanted vaccine)----3件: 46, 49, 271
337Folate1件: Folic acid1件: D00070 --3件: 41, 46, 49
338FolateScan (Technetium Tc 99mEC20)----4件: 13, 46, 49, 96
339Folic (or folinic) acid----1件: 46
340Folic acid1件: Folic acid1件: D00070 --5件: 6, 46, 49, 84, 296
341Folic acid (non-investigational product)1件: Folic acid1件: D00070 --1件: 46
342Folic acid or folate1件: Folic acid1件: D00070 --1件: 46
343Folic Acid, Vitamin B6, Vitamin B123件: Cyanocobalamin,
Folic acid,
Pyridoxine		6件: D00070 ,
D00166 ,
D03615 ,
D03616 ,
D03617 ,
D08454 		--1件: 6
344Folic/folinic acid1件: Leucovorin2件: D07986 ,
D07987 		--2件: 46, 107
345Foliglurax1件: Foliglurax---1件: 6
346Foliglurax 10 mg (treatment A)1件: Foliglurax---1件: 6
347Foliglurax 30 mg (treatment B)1件: Foliglurax---1件: 6
348Folimet----1件: 46
349Folinic acid1件: Leucovorin2件: D07986 ,
D07987 		--3件: 46, 107, 320
350Follow-up study of the treated cohort----1件: 193
351Fontolizumab1件: Fontolizumab1件: D04242 1件: IFNG 💬32件: African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 46
352Foralumab1件: Foralumab---2件: 13, 96
353Fordadistrogene movaparvovec1件: Fordadistrogene movaparvovec---1件: 113
354Forigerimod1件: Forigerimod1件: D09904 --1件: 49
355FORLAX 4 g, poudre pour solution buvable en sachet----1件: 299
356Formistin----1件: 13
357FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE----1件: 13
358Formistin 10 mg----1件: 13
359Formoterol1件: Formoterol1件: D07990 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 85, 228, 299
360Formoterol fumarate dihydrate1件: Formoterol1件: D07990 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
361Formoterol/Budesonide2件: Budesonide,
Formoterol		2件: D00246 ,
D07990 		2件: ADRB2,
NR3C1 💬		9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 228
362Formulation A----1件: 13
363Formulation B----1件: 13
364Formulation C----1件: 13
365Formulation D----1件: 13
366Forsteo1件: Teriparatide1件: D06078 1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬3件: 70, 235, 274
367FORSTEO-R1件: Teriparatide1件: D06078 1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235
368FORTECORTIN----2件: 28, 65
369Fortecortin Inject 40 mg Amp.----1件: 65
370Forteo1件: Teriparatide1件: D06078 1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 70
371Fortiral----1件: 6
372Fortum----1件: 299
373Forxiga1件: Dapagliflozin1件: D08897 1件: SLC5A2 💬-2件: 86, 88
374Forxiga (dapagliflozin)1件: Dapagliflozin1件: D08897 1件: SLC5A2 💬-2件: 86, 88
375FOS----2件: 66, 96
376Foscarbidopa1件: Foscarbidopa1件: D12057 --1件: 6
377Foscarbidopa and Foslevodopa2件: Foscarbidopa,
Foslevodopa		2件: D11839 ,
D12057 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
378Foscarnet1件: Foscarnet---1件: 60
379FosD----1件: 46
380Fosfamatinib Disodium----1件: 46
381Fosfato sodico de dexametasona1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96
382Fosfomycin1件: Fosfomycin1件: D04253 --2件: 96, 97
383FOSFOMYCIN DISODIUM1件: Fosfomycin1件: D04253 --1件: 97
384Foslevodopa1件: Foslevodopa1件: D11839 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
385Fosmetpantotenate----1件: 120
386Fosmetpantotenate (RE-024)----1件: 120
387FOSMETPANTOTENATE DRUG SUBSTANCE----1件: 120
388Fosmetpantotenato----1件: 120
389Fospropofol1件: Fospropofol---1件: 226
390Fospropofol (Lusedra®) 101件: Fospropofol---1件: 226
391Fospropofol (Lusedra®) 121件: Fospropofol---1件: 226
392Fospropofol (Lusedra®) 6.51件: Fospropofol---1件: 226
393Fostair----1件: 85
394Fostamatinib1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬4件: 46, 49, 61, 66
395Fostamatinib 100 mg1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66
396Fostamatinib 100 mg tablet1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66
397Fostamatinib 150 mg1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66
398Fostamatinib 150 mg bid1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 61
399Fostamatinib 150 mg tablet1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66
400Fostamatinib 50 mg blue film-coated tablet1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 46
401Fostamatinib Disodium1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬3件: 46, 61, 66
402Fostamatinib Disodium (R935788)1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬2件: 46, 49
403Fostamatinib Disodium tablet 100 mg1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66
404Fostamatinib Disodium tablet 150 mg1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66
405FP-110----1件: 97
406FP-CYA-050----1件: 97
407FP-CYA-053----1件: 97
408FPA008----1件: 46
409FPF 300 (thalidomide)1件: Thalidomide1件: D00754 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16
410FPF1011----1件: 263
411FPF1100NW----1件: 6
412FPFS-1169----1件: 6
413FPI-2620----1件: 127
414FR104----1件: 46
415Fragmin1件: Dalteparin---1件: 222
416Frameshift Array blood sample test----1件: 34
417Free amino acids intake1件: Amino acids---1件: 240
418Freeze-dried black raspberry powder1件: Raspberry1件: D09179 --1件: 97
419Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS)1件: Human immunoglobulin G---3件: 14, 43, 45
420Fremanezumab1件: Fremanezumab1件: D11055 1件: CALCA 💬2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬2件: 124, 226
421Fresenius-Kabi)----1件: 46
422Fresh Frozen Plasma----1件: 5
423Fresolimumab1件: Fresolimumab1件: D09620 3件: TGFB1,
TGFB2,
TGFB3 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬2件: 51, 222
424Frisium----1件: 140
425FRISIUM*30CPS 10MG----1件: 140
426FRM-0334----1件: 127
427From August 2020 'no additional treatment'----1件: 51
428Frondanol----1件: 97
429Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the a-L-iduronidase cDNA, in their final formulation medium.----1件: 19
430FSME-IMMUN----1件: 46
431FT011----1件: 51
432FT011 100 mg----1件: 51
433FT011 200 mg----1件: 51
434FTI, AZLI----1件: 299
435FTX-1821----1件: 113
436FTY720----2件: 13, 14
437FTY720D----1件: 13
438FTY720I----1件: 14
439Fucidin1件: Fusidic acid1件: D04281 --1件: 299
440Fucidin Tablets1件: Fusidic acid1件: D04281 --1件: 299
441Fucose1件: Fucose---1件: 65
442Fully human anti-interferon gamma monoclonal antibody1件: Interferon Gamma---1件: 107
443Fully human IgG1 monoclonal antibody specific for TL1A----2件: 96, 97
444Fully human IgG2 lambda monoclonal antibody----1件: 172
445Fully human monoclonal antibody directed against CXCL10----1件: 93
446Fully humanised, recombinant monoclonal antibody (IgG1)----1件: 96
447Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody----1件: 13
448Fultium-D3 800IU capsules----1件: 274
449Fulvestrant1件: Fulvestrant1件: D01161 2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 86
450Fumaderm----1件: 49
451Fumaderm®----1件: 49
452Fumaderm® initial----1件: 49
453Fumaric acid1件: Fumaric acid1件: D02308 --1件: 13
454FURESTEM-RA Inj----1件: 46
455FURESTEM-RA Inj.----1件: 46
456Furosemide1件: Furosemide1件: D00331 1件: SLC12A2 💬3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬2件: 6, 86
457Furosemide Injection1件: Furosemide1件: D00331 1件: SLC12A2 💬3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 6
458Fusidate1件: Fusidic acid1件: D04281 --1件: 299
459FUSIDIC ACID1件: Fusidic acid1件: D04281 --1件: 299
460Fusidin----1件: 299
461Fusion1件: Iron polymaltose---7件: 11, 13, 46, 49, 69, 70, 271
462Fuzhenghuayu----1件: 93
463Fx-1006A1件: Fx-1006A---1件: 28
464FX125L----1件: 46
465FXIIa inhibitor monoclonal antibody----1件: 85
466FXIII Concentrate (Human)----1件: 288
467FXIII Concentrate (Human) (FXIII)----1件: 288
468Fycompa1件: Perampanel1件: D08964 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬		16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬2件: 2, 144